GVP Module VI: An Overview
A clear overview of GVP Module VI, explaining ICSR requirements, timelines, and EudraVigilance reporting in the EU.
Vaibhavi M. | Jan 20, 2026
GVP As A Growth Strategy: Turning Safety Data Into Competitive Advantage
How Good Pharmacovigilance Practices are evolving from compliance into a strategic growth and trust-building function in pharma.
Vaibhavi M. | Jan 20, 2026
Advantages and Limitations of Non-Viral Delivery Systems
A strategic look at non-viral drug delivery systems, their advantages, limitations, and growing role in RNA, gene, and precision therapies.
Mrudula Kulkarni | Jan 19, 2026
From Human Inspection To Machine Vision: The Future Of AI-Powered Contamination Detection In Pharma
AI vision systems are reshaping pharma quality control by detecting contamination faster, improving consistency, and strengthening compliance.
Simantini Singh Deo | Dec 24, 2025
The Antibiotic Resistance: Zosurabalpin And The War On Superbugs
Zosurabalpin is a first-in-class antibiotic targeting Gram-negative superbugs and offering new hope against antimicrobial resistance.
Vaibhavi M. | Dec 22, 2025
Subscribe to our Newsletter!
Be the first to get exclusive offers and the latest news